Pradžia › Kastračiai atspari prostatos vėžys › Texas
Kastračiai atspari prostatos vėžys klinikiniai tyrimai Texas
7 tyrimai dėl Kastračiai atspari prostatos vėžys ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Texas Oncology, Austin
- UT Southwestern Medical Center, Dallas
- Houston Metro Urology, Houston
- ir dar 2
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
- Michael E DeBakey VA Medical Center, Houston
- ir dar 1
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-25 · NCT07164443A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Dallas-Fort Worth, Fort Worth
- NEXT Houston, Houston
- NEXT Oncology, San Antonio
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-24 · NCT07719361Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site Number: 401, Houston
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-10 · NCT05997615Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
- Houston Methodist Hospital, Houston
Renkami dalyviai1 fazė
Amžius nuo 18 iki 100 · Vyrams · Atnaujinta 2026-08-13 · NCT05519449A Study of MGC026 in Participants With Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-11 · NCT06242470A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- NEXT Oncology, San Antonio
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-08-10 · NCT06067841Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.